A mesoporous MnO 2 -based nanoplatform with near infrared light-controlled nitric oxide delivery and tumor microenvironment modulation for enhanced antitumor therapy

Hai-Lin Zhang,Yi Wang,Qi Tang,Bing Ren,Shi-Ping Yang,Jin-Gang Liu
DOI: https://doi.org/10.1016/j.jinorgbio.2023.112133
IF: 4.336
2023-01-22
Journal of Inorganic Biochemistry
Abstract:A hollow mesoporous manganese dioxide-based (H-MnO 2 ) multifunctional nanoplatform, H-MnO 2 @@ (MAPRF NPs), was prepared for synergistic cancer treatment, in which a histone deacetylase inhibitor AFIPB was loaded in its hollow cavity and a ruthenium nitrosyl donor (Ru-NO) and a folic acid (FA) targeting group were covalently decorated on its covered polydopamine (PDA) layer. The MAPRF NPs showed tumor microenvironment (TME)-responsive properties of depletion of glutathione (GSH) to disrupt the antioxidant defense system and on-demand drug delivery. And the released Mn 2+ further catalyzed the decomposition of endogenous H 2 O 2 to produce highly toxic hydroxyl radicals (·OH) for enhanced chemodynamic therapy (CDT). Furthermore, upon 808 nm light irradiation MAPRF NPs exhibited controlled nitric oxide (NO) delivery and simultaneously produced significant photothermal effect. Consequently, MAPRF NPs showed high mortality toward cancer cells in the presence of 808 nm light irradiation. This work provides a paradigm of multimodal synergistic therapy that combines NO-based gas therapy with TME modulation for efficient antitumor therapy.
biochemistry & molecular biology,chemistry, inorganic & nuclear
What problem does this paper attempt to address?